Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 4;3(2):e200628.
doi: 10.1148/ryct.2021200628. eCollection 2021 Apr.

Cardiac MRI in Suspected Acute COVID-19 Myocarditis

Affiliations

Cardiac MRI in Suspected Acute COVID-19 Myocarditis

Julian A Luetkens et al. Radiol Cardiothorac Imaging. .

Abstract

Keywords: COVID-19; coronavirus; myocarditis; cardiac MRI; T1 mapping; T2 mapping.

Keywords: COVID-19; T1 mapping; T2 mapping; cardiac MRI; coronavirus; myocarditis.

PubMed Disclaimer

Figures

None
Graphical abstract
Summary of study results. (a) Composition of imaging findings found in our study cohort. Besides signs of active pulmonary coronavirus disease 2019 (COVID- 19) infection with pneumonic infiltrates and pleural effusions, participants with suspected acute COVID-19 associated myocarditis had an impaired left ventricular function, also with patterns of stress-induced cardiomyopathy in single cases (a midventricular type of stress-induced cardiomyopathy with corresponding diastolic and systolic images is shown). As a key finding a distinct diffuse myocardial edema (detected with myocardial T1 and T2 mapping) was present in most participants. Late gadolinium enhancement lesions (white arrows) were less pronounced, especially when compared to participants with non-COVID-19 myocarditis. Late gadolinium enhancement lesions were present in the subepicardium of the lateral wall or in the basal septal midmyocardium. Some participants displayed pericardial enhancement or small pericardial effusions (see white arrows on corresponding images). All image examples are from the described study cohort of participants. (b) Column graphs with individual plotted values show distribution of quantitative myocardial MRI parameters in healthy participants and in participants with suspected acute non-COVID-19 and COVID-19 myocarditis. Distributions are given for native myocardial T1 relaxation time, myocardial T2 relaxation time, and extracellular volume fraction. Data are presented as mean with standard deviation error bars. The figure contains a free medical image from Servier (https://smart.servier.com/). * indicates significant pairwise comparison (P < .05). LVEF = left ventricular ejection fraction; ANOVA = analysis of variance; ECV = extracellular volume fraction.
Figure:
Summary of study results. (a) Composition of imaging findings found in our study cohort. Besides signs of active pulmonary coronavirus disease 2019 (COVID- 19) infection with pneumonic infiltrates and pleural effusions, participants with suspected acute COVID-19 associated myocarditis had an impaired left ventricular function, also with patterns of stress-induced cardiomyopathy in single cases (a midventricular type of stress-induced cardiomyopathy with corresponding diastolic and systolic images is shown). As a key finding a distinct diffuse myocardial edema (detected with myocardial T1 and T2 mapping) was present in most participants. Late gadolinium enhancement lesions (white arrows) were less pronounced, especially when compared to participants with non-COVID-19 myocarditis. Late gadolinium enhancement lesions were present in the subepicardium of the lateral wall or in the basal septal midmyocardium. Some participants displayed pericardial enhancement or small pericardial effusions (see white arrows on corresponding images). All image examples are from the described study cohort of participants. (b) Column graphs with individual plotted values show distribution of quantitative myocardial MRI parameters in healthy participants and in participants with suspected acute non-COVID-19 and COVID-19 myocarditis. Distributions are given for native myocardial T1 relaxation time, myocardial T2 relaxation time, and extracellular volume fraction. Data are presented as mean with standard deviation error bars. The figure contains a free medical image from Servier (https://smart.servier.com/). * indicates significant pairwise comparison (P < .05). LVEF = left ventricular ejection fraction; ANOVA = analysis of variance; ECV = extracellular volume fraction.

References

    1. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:802-810. - PMC - PubMed
    1. Giustino G, Pinney SP, Lala A, Reddy VY, Johnston-Cox HA, Mechanick JI, Halperin JL, et al. Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar. JAm Coll Cardiol 2020;76:2011-2023. - PMC - PubMed
    1. Esposito A, Palmisano A, Natale L, Ligabue G, Peretto G, Lovato L, Vignale D, et al. Cardiac Magnetic Resonance Characterization of Myocarditis-Like Acute Cardiac Syndrome in COVID-19. JACC Cardiovasc Imaging 2020;13:2462-2465. - PMC - PubMed
    1. Luetkens JA, Faron A, Isaak A, Dabir D, Kuetting D, Feisst A, Schmeel FC, et al. Comparison of Original and 2018 Lake Louise Criteria for Diagnosis of Acute Myocarditis: Results of a Validation Cohort. Radiology: Cardiothoracic Imaging 2019;1:e190010. - PMC - PubMed
    1. Isaak A, Praktiknjo M, Jansen C, Faron A, Sprinkart AM, Pieper CC, Chang J, et al. Myocardial Fibrosis and Inflammation in Liver Cirrhosis: MRI Study of the Liver-Heart Axis. Radiology 2020;297:51-61. - PubMed

LinkOut - more resources